Enhancing the Technology of Clinical Trials and the Trials Model to Evaluate Newly Developed, Targeted Antidepressants

Author： Katz M.M.   Halbreich U.M.   Bowden C.L.   Frazer A.   Pinder R.M.   Rush A.J.   Wheatley D.P.   Lebowitz B.D.  

Publisher： Elsevier

ISSN： 0893-133X

Source： Neuropsychopharmacology, Vol.27, Iss.3, 2002-09, pp. : 319-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancing the Quality of Laboratory Results in Clinical Trials

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 37-42

Bentham Science Publishers

Access to resources Recommend Favorite

Enhancing Trial Integrity by Protecting the Independence of Data Monitoring Committees in Clinical Trials

By        

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 968-975

Taylor & Francis Ltd

Access to resources Recommend Favorite

Targeted survival improvements in clinical trials: Are you an absolutist or relativist?

By Paul James  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 335-338

Blackwell Publishing

Access to resources Recommend Favorite

The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2279-2284

Bentham Science Publishers

Access to resources Recommend Favorite

New Directions for Clinical Trials of Targeted Alpha Therapy for Metastatic Melanoma

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 240-250

Bentham Science Publishers

Access to resources Recommend Favorite